REFERENCES
- Young D. National Pharmaceutical Stockpile aids homeland health security. Am J Health-Syst Pharm 2001; 58: 2115–2116
- Pesik N, Keim ME, Iserson KV. Terrorism and the ethics of emergency medical care. Ann Emerg Med 2001; 37: 642–646
- Simon JD. Nuclear, biological, and chemical terrorism: understanding the threat and designing responses. Int J Emerg Ment Health 1999; 1: 81–89
- Bradley RN. Health care facility preparation for weapons of mass destruction. Prehosp Emerg Care 2000; 4: 261–269
- Alexander GA. Ecoterrorism and nontraditional military threats. Mil Med 2000; 165: 1–5
- Macintyre AG, Christopher GW, Eitzen E, Jr, Gum R, Weir S, DeAtley C, Tonat K, Barbera JA. Weapons of mass destruction events with contaminated casualties: effective planning for health care facilities. J Am Med Assoc 2000; 283: 242–249
- Waeckerle JF. Domestic preparedness for events involving weapons of mass destruction. J Am Med Assoc 2000; 283(2)252–254
- Zilinskas RA. Iraq's biological weapons. The past as future?. J Am Med Assoc 1997; 278: 418–424
- Orient JM. Chemical and biological warfare. Should defenses be researched and deployed?. J Am Med Assoc 1989; 262: 644–648
- Sidel VW. Weapons of mass destruction: the greatest threat to public health. J Am Med Assoc 1989; 262: 680–682
- DeLorenzo RA. Exposed. Signs, symptoms & EMS management of nerve-agent poisoning. J Emerg Med Serv 2001; 26: 48–57
- Katzman S. Preparing for the worst. The USA and Japan's preparations for a terrorist attack with chemical or biological weapons. EMBO Rep 2000; 1: 387–389
- Grabenstein J, Downs K, Dotson D. Extraordinary infections: a focus on bioterrorism. J Am Pharm Assoc (Wash) 2000; 40: S36–S37
- , Internet resources related to biological and chemical terrorism. J Public Health Manag Pract. 2000; 6:68–69.
- , Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Morb Mortal Wkly Rep. 2000; 49:1–14.
- Franz DR, Zajtchuk R. Biological terrorism: understanding the threat, preparation, and medical response. Dis Mon 2000; 46: 125–190
- Lallement G, Clarencon D, Galonnier M, Baubichon D, Burckhart MF, Peoc'h M. Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support. Arch Toxicol 1999; 73: 115–122
- Maniscalco PM, Christen HT, Rubin DL, Kim P. Terrorism. Part 1: calibrating your risks and response. J Emerg Med Serv 1998; 23: 38–40, 42–44, 46–51
- Slater MS, Trunkey DD. Terrorism in America. An evolving threat. Arch Surg 1997; 132: 1059–1066
- Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW, Eitzen EM Jr. Clinical recognition and management of patients exposed to biological warfare agents. J Am Med Assoc 1997; 278: 399–411
- Sidell FR, Borak J. Chemical warfare agents: II. nerve agents. Ann Emerg Med 1992; 21: 865–871
- Borak J, Sidell FR. Agents of chemical warfare: sulfur mustard. Ann Emerg Med 1992; 21: 303–308
- Tucker JB. National health and medical services response to incidents of chemical and biological terrorism. J Am Med Assoc 1997; 278: 362–368
- Dart RC, Stark Y, Fulton B, Koziol-McLain J, Lowenstein SR. Insufficient stocking of poisoning antidotes in hospital pharmacies. J Am Med Assoc 1996; 276: 1508–1510
- Woolf AD, Chrisanthus K. On-site availability of selected antidotes: results of a Survey of Massachusetts Hospitals. Am J Emerg Med 1997; 15: 62–66
- Chyka PA, Conner HG. Availability of antidotes in rural and urban hospitals in Tennessee. Am J Hosp Pharm 1994; 51: 1346–1348